Plexāā, Panasonic Manufacturing UK Partner to Manufacture Breast Cancer Surgery Prep Device

A London-based medical device startup, Plexāā, has partnered with Panasonic Manufacturing UK as their contract manufacturer for its BLOOM⁴³ medical device.

The BLOOM⁴³ platform is designed to help patients prepare for breast cancer surgery and reconstruction with supraphysiological preconditioning. This technique intermittently heats the skin causing the release of heat-shock proteins, which causes vasodilation and increased blood flow to the area. This has been shown to reduce wound healing complications in proof-of-concept clinical trials.

Dr. Saahil Mehta, Founder of Plexāā, commented, “Partnering with Panasonic Manufacturing UK marks a crucial milestone for us. Their renowned expertise in manufacturing excellence & commitment to green manufacturing will enable us to efficiently bring the device to market and scale up globally in-line with demand.”

The BLOOM⁴³ device is currently being trialed at Stanford University Hospital, California and the company is preparing for a market launch in the U.S. in spring 2025.

Robert Blowers, Managing Director of Panasonic Manufacturing UK, said, “We are proud to partner with Plexāā on this exciting project. This collaboration not only highlights our ability to work across industries but also demonstrates our precision manufacturing expertise. We look forward to delivering high-quality products that will have a meaningful impact to patients.”

Panasonic Manufacturing UK recently expanded its operations to include a state-of-the-art RE100 application, based on its own hydrogen fuel cell technology. It is designed to run the home appliance facility on 100% renewable energy, which is a first of its kind in Europe.

The first manufactured products are expected in early 2025.